AKT1 and graft versus host disease: A recent study from our laboratory demonstrated that ex-vivo treatment of donor cells with WA could ameliorate the onset of Graft versus Host Disease (GvHD) in mouse model of allogeneic bone marrow transplantation by modulating Akt-mTOR signaling pathway [17].